Explore All Access
Check if your research matches the topics covered in Future Oncology?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Future Oncology : Impact Factor & More
eISSN: 1744-8301pISSN: 1479-6694
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Future Oncology Key Metrics
CiteScore 
4.9
Impact Factor
< 5
SNIP
0.82
Topics Covered on Future Oncology
Cancer
Lung cancer
Adjuvant
Curcumin
Chemotherapy
Immunotherapy
Crizotinib
Hepatocellular carcinoma
Overall survival
Genotype
Breast cancer
Dexamethasone
Neuroendocrine tumors
Prostate cancer
Gefitinib
Respiratory system
Standard deviation
Sunlight
Clinical trial
Hepatitis B
Future Oncology Journal Specifications
| Overview | |
| Publisher | FUTURE MEDICINE LTD |
| Language | English |
| Frequency | Fortnightly |
| General Details | |
| Language | English |
| Frequency | Fortnightly |
| Publication Start Year | 2005 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Future Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Future Oncology
Real-world clinical outcomes and economic burden of metastatic pancreatic ductal adenocarcinoma: a systematic review.
- 8 Dec 2024
- Future oncology (London, England)
A study to learn how well quizartinib with chemotherapy works and how safe it is in people with acute myeloid leukemia that is FLT3-ITD-positive: a plain language summary of the QuANTUM-First study.
- 4 Dec 2024
- Future oncology (London, England)
A plain language summary of results from the CHOICE-01 trial of toripalimab plus chemotherapy for advanced non-small cell lung cancer (NSCLC).
- 4 Dec 2024
- Future oncology (London, England)
A plain language summary of results from the TORCHLIGHT trial of toripalimab plus chemotherapy for metastatic or recurrent triple-negative breast cancer.
- 4 Dec 2024
- Future oncology (London, England)
Plain language summary: updated results of lorlatinib treatment in people with advanced NSCLC from China.
- 2 Dec 2024
- Future oncology (London, England)
Decoding clinical trial jargon: helping people understand how safety and quality of life are assessed in cancer trials
- 2 Dec 2024
- Future Oncology
Real-world clinical outcomes and economic burden of metastatic pancreatic ductal adenocarcinoma: a systematic review.
- 8 Dec 2024
- Future oncology (London, England)
A study to learn how well quizartinib with chemotherapy works and how safe it is in people with acute myeloid leukemia that is FLT3-ITD-positive: a plain language summary of the QuANTUM-First study.
- 4 Dec 2024
- Future oncology (London, England)
A plain language summary of results from the CHOICE-01 trial of toripalimab plus chemotherapy for advanced non-small cell lung cancer (NSCLC).
- 4 Dec 2024
- Future oncology (London, England)
A plain language summary of results from the TORCHLIGHT trial of toripalimab plus chemotherapy for metastatic or recurrent triple-negative breast cancer.
- 4 Dec 2024
- Future oncology (London, England)
Plain language summary: updated results of lorlatinib treatment in people with advanced NSCLC from China.
- 2 Dec 2024
- Future oncology (London, England)
Decoding clinical trial jargon: helping people understand how safety and quality of life are assessed in cancer trials
- 2 Dec 2024
- Future Oncology
Compare Similar Journals with Future Oncology
Select Journals to Compare with Future Oncology
Total journals - 10
You can select up to 3 Journals at a time
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Annals of Oncology
Publisher: ELSEVIER
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Cancers
Publisher: MDPI
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
BMC Cancer
Publisher: BMC
Cancer Medicine
Publisher: WILEY
European Journal of Cancer
Publisher: ELSEVIER SCI LTD
Oncotarget
Publisher: Impact Journals
Clinical Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
0 Journals Selected to compare with
Future Oncology
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Future Oncology
How long has Future Oncology been actively publishing? 
Future Oncology has been in operation since 2005 till date.
What is the publishing frequency of Future Oncology?
Future Oncology published with a Fortnightly frequency.
How many articles did Future Oncology publish last year?
In 2023, Future Oncology publsihed 296 articles.
What is the eISSN & pISSN for Future Oncology?
For Future Oncology, eISSN is 1744-8301 and pISSN is 1479-6694.
What is Citescore for Future Oncology?
Citescore for Future Oncology is 4.9.
What is SNIP score for Future Oncology?
SNIP score for Future Oncology is 0.82.
Who is the publisher of Future Oncology?
FUTURE MEDICINE LTD is the publisher of Future Oncology.
